Journal of the Neurological Sciences
Volume 287, Issue 1 , Pages 7-16 , 15 December 2009

Susceptibility-weighted imaging for differential diagnosis of cerebral vascular pathology: A pictorial review

  • Yu-Kun Tsui

      Affiliations

    • Department of Radiological Sciences, University of California Irvine Medical Center, 101 City Drive South, Orange, CA 92868, USA
    • Department of Radiology, Chi Mei Medical Center, Yong-Kang City, Tainan, Taiwan
  • ,
  • Fong Y. Tsai

      Affiliations

    • Department of Radiological Sciences, University of California Irvine Medical Center, 101 City Drive South, Orange, CA 92868, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1 714 456 6984; fax: +1 714 456 8390.
  • ,
  • Anton N. Hasso

      Affiliations

    • Department of Radiological Sciences, University of California Irvine Medical Center, 101 City Drive South, Orange, CA 92868, USA
  • ,
  • Fred Greensite

      Affiliations

    • Department of Radiological Sciences, University of California Irvine Medical Center, 101 City Drive South, Orange, CA 92868, USA
  • ,
  • Binh V. Nguyen

      Affiliations

    • Department of Radiological Sciences, University of California Irvine Medical Center, 101 City Drive South, Orange, CA 92868, USA

Received 5 February 2009 ,Revised 26 August 2009 ,Accepted 28 August 2009.

References 

  1. Reichenbach JR, Venkatesan R, Schillinger DJ, Kido DK, Haacke EM. Small vessels in the human brain: MR venography with deoxyhemoglobin as an intrinsic contrast agent. Radiology. 1997;204:272–277
  2. Reichenbach JR, Jonetz-Mentzel L, Fitzek C, Haacke EM, Kido DK, Lee BC, et al. High-resolution blood oxygen-level dependent MR venography (HRBV): a new technique. Neuroradiology. 2001;43:364–369
  3. Reichenbach JR, Haacke EM. High-resolution BOLD venographic imaging: a window into brain function. NMR Biomed. 2001;14:453–467
  4. Haacke EM, Xu Y, Cheng YC, Reichenbach JR. Susceptibility weighted imaging (SWI). Magn Reson Med. 2004;52:612–618
  5. Cho ZH, Ro YM, Lim TH. NMR venography using the susceptibility effect produced by deoxyhemoglobin. Magn Reson Med. 1992;28:25–38
  6. Lee BC, Vo KD, Kido DK, Mukherjee P, Reichenbach J, Lin W, et al. MR high-resolution blood oxygenation level dependent venography of occult (low-flow) vascular lesions. AJNR Am J Neuroradiol. 1999;20:1239–1242
  7. Sehgal V, Delproposto Z, Haacke EM, Tong KA, Wycliffe N, Kido DK, et al. Clinical applications of neuroimaging with susceptibility-weighted imaging. J Magn Reson Imaging. 2005;22:439–450
  8. Tong KA, Ashwal S, Obenaus A, Nickerson JP, Kido D, Haacke EM. Susceptibility-weighted MR imaging: a review of clinical applications in children. AJNR Am J Neuroradiol. 2008;29:9–17
  9. Tong KA, Ashwal S, Holshouser BA, Nickerson JP, Wall CJ, Shutter LA, et al. Diffuse axonal injury in children: clinical correlation with hemorrhagic lesions. Ann Neurol. 2004;56:36–50
  10. Tong KA, Ashwal S, Holshouser BA, Shutter LA, Herigault G, Haacke EM, et al. Hemorrhagic shearing lesions in children and adolescents with posttraumatic diffuse axonal injury: improved detection and initial results. Radiology. 2003;227:332–339
  11. Essig M, Reichenbach JR, Schad L, Debus J, Kaiser WA. High resolution MR-venography of cerebral arteriovenous malformations. Radiologe. 2001;41:288–295
  12. Sehgal V, Delproposto Z, Haddar D, Haacke EM, Sloan AE, Zamorano LJ, et al. Susceptibility-weighted imaging to visualize blood products and improve tumor contrast in the study of brain masses. J Magn Reson Imaging. 2006;24:41–51
  13. Tan IL, van Schijndel RA, Pouwels PJ, van Walderveen MA, Reichenbach JR, Manoliu RA, et al. MR venography of multiple sclerosis. AJNR Am J Neuroradiol. 2000;21:1039–1042
  14. Hermier M, Nighoghossian N. Contribution of susceptibility-weighted imaging to acute stroke assessment. Stroke. 2004;35:1989–1994
  15. Thomas B, Somasundaram S, Thamburaj K, Kesavadas C, Gupta AK, Bodhey NK, et al. Clinical applications of susceptibility weighted imaging of brain-A pictorial review. Neuroradiology. 2008;50:105–116
  16. Rauscher A, Sedlacik J, Barth M, Mentzel HJ, Reichenbach JR. Magnetic susceptibility-weighted MR phase imaging of the human brain. AJNR Am J Neuroradiol. 2005;26:736–742
  17. De Souza JM, Domingues RC, Cruz LC, Domingues FS, Iasbeck T, Gasparetto EL. Susceptibility-weighted imaging for the evaluation of patients with familial cerebral cavernous malformations: a comparison with T2-weighted fast spin-echo and gradient-echo sequences. AJNR Am J Neuroradiol. 2008;29:154–158
  18. Thulborn KR, Waterton JC, Matthews PM, Radda GK. Oxygenation dependence of the transverse relaxation time of water protons in whole blood at high field. Biochim Biophys Acta. 1982;714:265–270
  19. Li D, Waight DJ, Wang Y. In vivo correlation between blood T2* and oxygen saturation. J Magn Reson Imaging. 1998;8:1236–1239
  20. Haacke EM, Lai S, Reichenbach JR, Kuppusamy K, Hoogenraad FGC, Takeichi H, et al. In vivo measurement of blood oxygen saturation using magnetic resonance imaging: a direct validation of the blood oxygen level-dependent concept in functional brain imaging. Hum Brain Mapp. 1997;5:341–346
  21. Cheng YCN, Haacke EM. Predicting BOLD signal changes as a function of blood volume fraction and resolution. NMR Biomed. 2001;14:468–477
  22. Haacke EM, Mittal S, Wu Z, Neelavalli J, Cheng YC. Susceptibility-weighted imaging: technical aspects and clinical applications, part 1. AJNR Am J Neuroradiol. 2009;30:19–30
  23. Mittal S, Wu Z, Neelavalli J, Haacke EM. Susceptibility-weighted imaging: technical aspects and clinical applications, part 2. AJNR Am J Neuroradiol. 2009;30:232–252
  24. Lin W, Mukherjee P, An H, Yu Y, Wang Y, Vo K, et al. Improving high-resolution MR bold venographic imaging using a T1 reducing contrast agent. J Magn Reson Imaging. 1999;10:118–123
  25. Essig M, Reichenbach JR, Schad LR, Schoenberg SO, Debus J, Kaiser WA. High-resolution MR venography of cerebral arteriovenous malformations. Magn Reson Imaging. 1999;17:1417–1425
  26. Garner TB, Del Curling O, Kelly DL, Laster DW. The natural history of intracranial venous angiomas. J Neurosurg. 1991;75:715–722
  27. Abe T, Singer RJ, Marks MP, Norbash AM, Crowley RS, Steinberg GK. Coexistence of occult vascular malformations and developmental venous anomalies in the central nervous system: MR evaluation. AJNR Am J Neuroradiol. 1998;19:51–57
  28. Fushimi Y, Miki Y, Togashi K, Kikuta K, Hashimoto N, Fukuyama H. A developmental venous anomaly presenting atypical findings on susceptibility-weighted imaging. AJNR Am J Neuroradiol. 2008;29:E56
  29. Kim DS, Park YG, Choi JU, Chung SS, Lee KC. An analysis of the natural history of cavernous malformations. Surg Neurol. 1997;48:9–17
  30. Labauge P, Brunereau L, Levy C, Laberge S, Houtteville JP. The natural history of familial cerebral cavernomas: a retrospective MRI study of 40 patients. Neuroradiology. 2000;42:327–332
  31. Cooper AD, Campeau NG, Meissner I. Susceptibility-weighted imaging in familial cerebral cavernous malformations. Neurology. 2008;71:382
  32. Huddle DC, Chaloupka JC, Sehgal V. Clinically aggressive diffuse capillary telangiectasia of the brain stem: a clinical radiologic–pathologic case study. AJNR Am J Neuroradiol. 1999;20:1674–1677
  33. Lee RR, Becher MW, Benson ML, Rigamonti D. Brain capillary telangiectasia: MR imaging appearance and clinicohistopathologic findings. Radiology. 1997;205:797–805
  34. Yoshida Y, Terae S, Kudo K, Tha KK, Imamura M, Miyasaka K. Capillary telangiectasia of the brain stem diagnosed by susceptibility-weighted imaging. J Comput Assist Tomogr. 2006;30:980–982
  35. McCormick WF. Pathology of vascular malformations of the brain. In:  Wilson CB,  Stein BM editor. Intracranial Arteriovenous Malformations. Baltimore: Wiliams & Wilkins; 1984;p. 44–63
  36. Juhasz C, Haacke EM, Hu J, Xuan Y, Makki M, Behen ME, et al. Multimodality imaging of cortical and white matter abnormalities in Sturge–Weber syndrome. AJNR Am J Neuroradiol. 2007;28:900–906
  37. Mammen EF. Pathogenesis of venous thrombosis. Chest. 1992;102:640s–644s
  38. Liang L, Korogi Y, Sugahara T, Shigematsu Y, Okuda T, Ikushima I, et al. Detection of intracranial hemorrhage with susceptibility weighted MR sequences. AJNR Am J Neuroradiol. 1999;20:1527–1534
  39. Flacke S, Urbach H, Keller E, Traber F, Hartmann A, Textor J, et al. Middle cerebral artery (MCA) susceptibility sign at susceptibility-based perfusion MR imaging: clinical importance and comparison with hyperdense MCA sign at CT. Radiology. 2000;215:476–482
  40. Chalela JA, Haymore JB, Ezzeddine MA, Davis LA, Warach S. The hypointense MCA sign. Neurology. 2002;58:1470
  41. Grohn OHJ, Kauppinen RA. Assessment of brain tissue viability in acute ischemic stroke by BOLD MRI. NMR Biomed. 2001;14:432–440
  42. Hermier M, Nighoghossian N, Derex L, Adeleine P, Wiart M, Berthezene Y, et al. Hypointense transcerebral veins at T2*-weighted MRI: a marker of hemorrhagic transformation risk in patients treated by intravenous tissue plasminogen activator. J Cereb Blood Flow Metab. 2003;23:1362–1370
  43. Wu Z, Mittal S, Kish K, Yu Y, Hu J, Haacke EM. Identification of calcification with MRI using susceptibility-weighted imaging: a case study. J Magn Reson Imaging. 2009 Jan;29:177–182
  44. Provenzale JM. Dissection of the internal carotid and vertebral arteries: imaging features. AJR Am J Roentgenol. 1995;165:1099–1104
  45. Yoshimoto Y, Hoya K, Tanaka Y, Uchida T. Basilar artery dissection. J Neurosurg. 2005;102:476–481
  46. Bousser MG, Chiras J, Bories J, Castaigne P. Cerebral venous thrombosis—a review of 38 cases. Stroke. 1985;16:199–213
  47. Ameri A, Bousser MG. Cerebral venous thrombosis. Neurol Clin. 1992;10:87–111
  48. Tsai FY, Wang AM, Matovich VB. MR staging of acute dural sinus thrombosis: correlation with venous pressure measurements and implications for treatment and prognosis. AJNR Am J Neuroradiol. 1995;16:1021–1029
  49. Roberts HC, Lee TJ, Higashida RT. Imaging and endovascular therapy of cerebral venous and dural sinus thrombosis. In:  Latchaw RE,  Kucharczyk J,  Moseley ME editor. Imaging of the Nervous System: Diagnostic and Therapeutic Applications. Vol 1:Philadelphia, USA: Elsevier Mosby; 2005;p. 723–741
  50. Idbaih A, Boukobza M, Crassard I, Porcher R, Bousser MG, Chabriat H. MRI of clot in cerebral venous thrombosis: high diagnostic value of susceptibility-weighted images. Stroke. 2006;37:991–995
  51. Kwon BJ, Han MH, Kang HS, Chang KH. MR imaging findings of intracranial dural arteriovenous fistulas: relations with venous drainage patterns. AJNR Am J Neuroradiol. 2005;26:2500–2507
  52. Saini J, Thomas B, Bodhey NK, Periakaruppan A, Babulal JM. Susceptibility-weighted imaging in cranial dural arteriovenous fistulas. AJNR Am J Neuroradiol. 2009;30:E6
  53. King JO, Mitchell PJ, Thomson KR, Tress BM. Cerebral venography and manometry in idiopathic intracranial hypertension. Neurology. 1995;45:2224–2228
  54. Karahalios DG, Rekate HL, Khayata MH, Apostolides PJ. Elevated intracranial venous pressure as a universal mechanism in pseudotumor cerebri of varying etiologies. Neurology. 1996;46:198–202
  55. Sussman JD, Sarkies N, Pickard JD. Benign intracranial hypertension. Pseudotumour cerebri: idiopathic intracranial hypertension. Adv Tech Stand Neurosurg. 1998;24:261–305
  56. Biousse V, Ameri A, Bousser MG. Isolated intracranial hypertension as the only sign of cerebral venous thrombosis. Neurology. 1999;53:1537–1542
  57. Van Mook WN, Rennenberg RJ, Schurink GW, van Oostenbrugge RJ, Mess WH, Hofman PA, et al. Cerebral hyperperfusion syndrome. Lancet Neurol. 2005;4:877–888
  58. Rippy EE, Wolfe JH. Cerebral hyperperfusion syndrome—a case report and literature review. Vasc Endovasc Surg. 2002;36(4):291–295
  59. Ogasawara K, Konno H, Yukawa H, Endo H, Inoue T, Ogawa A. Transcranial regional cerebral oxygen saturation monitoring during carotid endarterectomy as a predictor of postoperative hyperperfusion. Neurosurgery. 2003;53:309–314
  60. Bell MJ, Robertson CS, Kochanek PM, Goodman JC, Gopinath SP, Carcillo JA, et al. Interstitial brain adenosine and xanthine increase during jugular venous oxygen desaturations in humans after traumatic brain injury. Crit Care Med. 2001;29:399–404

PII: S0022-510X(09)00837-5

doi: 10.1016/j.jns.2009.08.064

Journal of the Neurological Sciences
Volume 287, Issue 1 , Pages 7-16 , 15 December 2009